99mtc-hynic annexin-v imaging of primary head and neck carcinoma

Nuclear Medicine Communications

Volumn 25, Issue 3, 2004, Pages 259-263

  Vermeersch, Hubert ^a   Loose, David ^a   Lahorte, Christophe ^a   Mervillie, Kris ^a   Dierckx, Rudi ^a   Steinmetz, Neil ^a   Vanderheyden, Jean Luc ^a   Cuvelier, Claude ^a   Slegers, Guido ^a   Van de Wiele, Christophe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

99mTc HYNIC Annexin V; Computed tomography; Head and neck carcinoma

Indexed keywords

HYDRAZINONICOTINAMIDE ANNEXIN V TC 99M; LIPOCORTIN 5; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYNIC ANNEXIN V;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; HEAD AND NECK TUMOR; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MIDDLE AGED; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

AGED; ANNEXIN A5; FALSE NEGATIVE REACTIONS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 5144221644     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200403000-00008     Document Type: Article

References (28)

1. White E. Life, death and the pursuit of apoptosis. Gene Dev 1996; 10:1-15.
2. Dive C, Hickman JA. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 1991; 64:192-196.
3. Schmitt CA, Lowe S. Apoptosis and therapy. J Pathol 1999; 187:127-137.
4. Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis. Exp Cell Res 1999; 248:10-17.
5. Mesner P, Rudthardjo I, Kaufman SH. Chemotherapy induced apoptosis. Adv Pharmacol 1997; 41:461-499.
6. Kaufman SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256:42-49.
7. Wheeler JA, Stephens LC, Tornos C, Eifel PJ, Ang KK, Milas L, et al. ASTRO research fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical adenocarcinoma. Int J Radiat Oncol Biol Phys 1995; 32:1487-1493.
8. Chyle B, Pollack A, Bzerniak B, Stephens LC, Zagars CK, Terry NH, et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 1996; 35:281-287.
9. Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37:1-9.
10. Komaki R, Fujii T, Erkins P, Ro JY, Allen PK, Masoor KA, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1996; 36:601-605.
11. van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CP. Annexin-V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9.
12. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging local sites of infection in rats. J Nucl Med 1990; 31:2022-2028.
13. Green AM, Steinmetz ND. Monitoring apoptosis in real time. Cancer J 2002; 8:82-93.
14. Van deWiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, et al. Non-invasive quantitative tumour apoptosis imaging by means of 99mTc-HYNIC Annexin single photon emission computerized tomography. J Clin Oncol 2003; 66:1595-1599.
15. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
16. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996; 184:429-440.
17. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, et al. Targeted mutation in the Fas genes causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 1995; 11:294-300.
18. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, et al. Apoptotic role of the Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999; 93 (3):796-803.
19. Ricketts C, Jacobs A, Cavill I. Ferrokinetics and erythropoiesis in man. The measurement of effective and ineffective erythropoiesis and red lifespan using 59Fe. Br J Haematol 1975; 31:65-75.
20. Samson D, Tikerpae J, Crowne H. A simple in vitro method for the assessment of ineffective erythropoiesis. Blood 1981; 58:782-787.
21. Gastman BR, Atarshi Y, Reichert TE, Sarto T, Balkir L, Rabinowich H, et al. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 1999; 59:5356-5364.
22. Mundle SD, Gao XZ, Khan S, Gregory SA, Preisler HD, Razz A. Two in situ end labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res 1995; 15:1895-1904.
23. Nagler R, Kerner H, Laufer D, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002; 186 (2):137-150.
24. Loro LL, Vintermeyr OK, Liavaag PG, Jonnson R, Johanessen AC. Oral squamous cell carcinoma is associated with decreased Bcl-2/Bax expression ratio and increased apoptosis. Hum Pathol 1999; 30:1097-1105.
25. Barnhill RL, Piepkorn MW, Cochran AJ, Flynn E, Karaoli T, Folkman J. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998; 134 (8):1027-1028.
26. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotine nick end labeling. Int J Cancer 1996; 65 (2):173-177.
27. Van de Wiele C, Vermeersch H, Loose D, Signore A, Mertens N, Dierckx RA. Radiolabelled annexin-V for monitoring treatment response in oncology. Cancer Biother Radiopharm 2003; in press.
28. Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, et al. Increased uptake of the apoptosis-imaging agent 99mTc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 2002; 8:2766-2774.